Fund Holdings — Avoro Capital Advisors LLC

Total Portfolio Value:
$7.51B
Total Bought:
$399.99M
Total Sold:
$1.13B
Net Transaction:
-$726.05M
Notable People:
Behzad Aghazadeh, Avoro Capital L.P.
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
United Therapeutics Corporation(UTHR)2,858,8882,858,8880$656.74M$910.70M12.13%+$253.96M
Madrigal Pharmaceuticals, Inc.(MDGL)1,944,4442,055,555+111,111$519.24M$575.88M7.67%+$56.64M
Ascendis Pharma A/SADR(ASND)3,966,6664,196,661+229,995$599.64M$572.34M7.62%-$27.30M
argenx SEADR(ARGX)1,238,4671,238,4670$487.61M$532.59M7.09%+$44.98M
Sarepta Therapeutics, Inc.(SRPT)4,344,4443,000,000-1,344,444$562.43M$474.00M6.31%-$88.43M
Krystal Biotech, Inc.(KRYS)2,555,5552,433,000-122,555$454.71M$446.80M5.95%-$7.91M
Apellis Pharmaceuticals Inc.
COM
11,111,11111,111,1110$653.11M$426.22M5.68%-$226.89M
BioMarin Pharmaceutical Inc.(BMRN)4,365,0004,557,416+192,416$381.24M$375.21M5.00%-$6.03M
Cerevel Therapeutics Hldng7,555,5557,539,547-16,008$319.37M$308.29M4.11%-$11.08M
Spdr Series Trust - S&p BiotechETF
ST STR SP BIOT
4,300,0003,035,000-1,265,000$408.03M$281.37M3.75%-$126.65M
Amicus Therapeutics Inc.
COM
27,400,00027,400,0000$322.77M$271.81M3.62%-$50.96M
Avidity Biosciences Inc5,825,0006,505,000+680,000$148.65M$265.73M3.54%+$117.08M
Arrowhead Pharmaceuticals, Inc.(ARWR)8,555,5558,888,888+333,333$244.69M$231.02M3.08%-$13.67M
Xenon Pharmaceuticals Inc.(XENE)5,666,6665,666,6660$243.95M$220.94M2.94%-$23.01M
Intra-Cellular Therapies Inc2,475,0003,000,000+525,000$171.27M$205.47M2.74%+$34.20M
Vera Therapeutics, Inc.(VERA)5,265,0004,309,590-955,410$227.03M$155.92M2.08%-$71.11M
MoonLake ImmunotherapeuticsCL A(MLTX)2,580,0002,770,000+190,000$129.59M$121.80M1.62%-$7.80M
Kymera Therapeutics, Inc.(KYMR)3,888,8883,888,8880$156.33M$116.08M1.55%-$40.25M
Alnylam Pharmaceuticals, Inc.(ALNY)300,000400,000+100,000$44.84M$97.20M1.29%+$52.37M
Iovance Biotherapeutics, Inc.(IOVA)11,700,00011,700,0000$173.39M$93.83M1.25%-$79.56M
Soleno Therapeutics Inc1,625,0002,091,666+466,666$69.55M$85.34M1.14%+$15.79M
Merus N V888,8881,355,000+466,112$40.03M$80.18M1.07%+$40.15M
Syndax Pharmaceuticals, Inc.(SNDX)4,222,2223,888,437-333,785$100.49M$79.83M1.06%-$20.66M
BioCryst Pharmaceuticals, Inc.(BCRX)13,050,00012,570,000-480,000$66.29M$77.68M1.03%+$11.39M
Kura Oncology, Inc.(KURA)3,850,0003,541,505-308,495$82.12M$72.92M0.97%-$9.20M
Ocular Therapeutix, Inc.(OCUL)7,148,9368,060,000+911,064$65.06M$55.13M0.73%-$9.92M
MannKind Corporation(MNKD)9,000,0008,759,524-240,476$40.77M$45.72M0.61%+$4.95M
Vaxcyte, Inc.(PCVX)575,000575,0000$39.28M$43.42M0.58%+$4.14M
Spyre Therapeutics, Inc.(SYRE)1,839,1381,839,1380$69.76M$43.24M0.58%-$26.52M
Autolus Therapeutics plcADR(AUTL)12,345,67812,345,6780$78.77M$42.96M0.57%-$35.80M
Taysha Gene Therapies, Inc.(TSHA)18,650,00018,650,0000$53.53M$41.78M0.56%-$11.75M
Ultragenyx Pharmaceutical Inc.(RARE)830,000830,0000$38.75M$34.11M0.45%-$4.64M
Verrica Pharmaceuticals Inc.(VRCA)3,999,9993,999,9990$23.68M$29.16M0.39%+$5.48M
Tourmaline Bio Inc2,222,2222,222,2220$50.89M$28.58M0.38%-$22.31M
CG Oncology, Inc.(CGON)700,000700,0000$30.73M$22.10M0.29%-$8.63M
Monte Rosa Therapeutics, Inc.(GLUE)4,535,0004,535,0000$31.97M$16.96M0.23%-$15.01M
Bicycle Therapeutics PlcADR0700,000+700,000$0$14.17M0.19%+$14.17M
Whitehawk Therapeutics, Inc.(WHWK)2,849,4022,849,4020$6.67M$4.16M0.06%-$2.51M
Dyne Therapeutics, Inc.(DYN)0115,751+115,751$0$4.08M0.05%+$4.08M
Adverum Biotechnologies Inc416,666416,6660$5.89M$2.86M0.04%-$3.03M
Neurogene Inc.(NGNE)022,029+22,029$0$801.6K0.01%+$801.6K
Alpine Immune Sciences Inc5,775,0000-5,775,000$228.92M$0—-$228.92M
CRISPR Therapeutics AG(CRSP)419,5800-419,580$28.60M$0—-$28.60M
Kyverna Therapeutics, Inc.(KYTX)475,0000-475,000$11.80M$0—-$11.80M
MacroGenics, Inc.(MGNX)6,150,0000-6,150,000$90.53M$0—-$90.53M
Marinus Pharmaceuticals Inc4,140,6070-4,140,607$37.43M$0—-$37.43M
Rocket Pharmaceuticals, Inc.(RCKT)1,260,9000-1,260,900$33.97M$0—-$33.97M
Roivant Sciences Ltd.(ROIV)4,651,1620-4,651,162$49.02M$0—-$49.02M
Viking Therapeutics, Inc.(VKTX)3,590,0000-3,590,000$294.38M$0—-$294.38M
Page 1 of 1
Avoro Capital Advisors LLC — 13F Holdings — Q2 2024 | TickerTrail